The goal of drug developer Atossa Therapeutics is to "transform the breast cancer paradigm." | Steven C. Quay, CEO, ATOSSA THERAPEUTICS INC 00:10:00

Share On Facebook Share On Twitter

Founder of Atossa Therapeutics, Inc., Sonus Pharmaceuticals, Inc., Nycomed Salutar, Inc. and Salutar, Inc., Steven C. Quay is an entrepreneur and businessperson who has been at the helm of 5 different companies and presently holds the position of Chairman, President & Chief Executive Officer for Atossa Therapeutics, Inc. He is also Member of American Society for Investigative Pathology, Member of Association for Molecular Pathology, Member of Association for Pathology Informatics, Inc. and Member of Society for Laboratory Automation & Screening. In the past Steven C. Quay occupied the position of Chairman & Chief Scientific Officer at Silverleaf Resorts, Inc., Chairman, President & Chief Executive Officer at Atossa HealthCare, Inc., Chairman & President of National Reference Laboratory For Breast Health, Inc. and President & Chief Executive Officer at Sonus Pharmaceuticals, Inc. Dr. Quay received an undergraduate degree from Western Michigan University and a doctorate from the University of Michigan Medical School.

Recent Videos